Skip to main content
. 2014 Dec 23;59(1):178–185. doi: 10.1128/AAC.03684-14

FIG 4.

FIG 4

Mean free (unbound) drug plasma exposure concentrations at steady state for therapeutic-dose tedizolid (200 mg once daily; circles) and linezolid (600 mg twice daily; triangles) over the course of the dosing interval, based on published values (25, 41), in relation to the MPS IC50 of each agent.